Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Conditions:   Alzheimer Disease;   Dementia Alzheimers;   Dementia;   Cognitive Impairment;   Mild Cognitive Impairment;   Neurodegenerative Diseases;   Neurocognitive Disorders;   Neurocognitive Dysfunction;   Cognitive Dysfunction;   Mental Disorder Intervention:   Device: Emerald Device Monitoring Sponsors:   Mclean Hospital;   National Institute on Aging (NIA) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials